Suppr超能文献

23价肺炎球菌多糖疫苗(PPSV23)的引入与日本普通老年人群肺炎发病率和死亡率之间的关联:一项基于社区的研究

Association Between Introduction of the 23-valent Pneumococcal Polysaccharide Vaccine (PPSV23) and Pneumonia Incidence and Mortality Among General Older Population in Japan: A Community-based Study.

作者信息

Sugiyama Aya, Kataoka Masaaki, Tokumo Kentaro, Abe Kanon, Imada Hirohito, Sun Bunlorn, Akuffo Golda Ataa, Akita Tomoyuki, Fukuma Shingo, Hattori Noboru, Tanaka Junko

机构信息

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University.

Project Research Center For Epidemiological & Mega-Data Analysis of New Research Area, Hiroshima University.

出版信息

J Epidemiol. 2025 May 5;35(5):237-244. doi: 10.2188/jea.JE20240285. Epub 2025 Mar 31.

Abstract

BACKGROUND

With global aging, especially in Asia, preventing pneumonia among seniors is vital. The necessity of introducing pneumococcal vaccines among the elderly has been highlighted, but there is a paucity of community-based real-world evidence on their effect. Sera Town in Hiroshima Prefecture, a super-aged community, launched a distinctive pneumococcal vaccination support project for elderly residents and conducted a 5-year follow-up survey. This study evaluates the effectiveness of this vaccination initiative.

METHODS

From October 2010 to March 2015, Sera Town recruited elderly residents for PPSV23 vaccination with partial cost subsidies. Participants were surveyed annually for 5 years post-vaccination to assess pneumonia incidence, calculated on a person-years basis. Using vital statistics from 2000 to 2016, we quantified changes in mortality rates associated with the vaccination support project through an interrupted-time-series analysis.

RESULTS

Of approximately 7,900 residents aged 65 and older, 3,422 (43%) participated in the project (median age: 84 years; range: 70-114 years; 56.7% female). Over 14,559 person-years of observation, 295 participants developed pneumonia. The post-vaccination incidence rate was 20.3 per 1,000 person-years (95% confidence interval [CI], 18.0-22.7). Interrupted time series analysis indicated a 25% reduction in Sera Town's pneumonia mortality rate post-project, reversing an annual increase of 0.23 per 1,000 population pre-project to an annual decrease of 0.04 per 1,000 population post-project.

CONCLUSION

This study provided real-world evidence on the association with PPSV23 vaccination on the general elderly through a community-based study. The results may be particularly useful for regions where PPSV23 serotypes are prevalent, offering insights for areas facing aging challenges.

摘要

背景

随着全球老龄化,尤其是在亚洲,预防老年人肺炎至关重要。老年人接种肺炎球菌疫苗的必要性已得到强调,但缺乏基于社区的关于其效果的真实世界证据。广岛县的世罗町是一个超老龄化社区,为老年居民启动了一项独特的肺炎球菌疫苗接种支持项目,并进行了为期5年的随访调查。本研究评估了该疫苗接种倡议的有效性。

方法

2010年10月至2015年3月,世罗町招募老年居民接种23价肺炎球菌多糖疫苗(PPSV23),并提供部分费用补贴。接种疫苗后每年对参与者进行调查,持续5年,以评估肺炎发病率,按人年计算。利用2000年至2016年的人口动态统计数据,我们通过中断时间序列分析量化了与疫苗接种支持项目相关的死亡率变化。

结果

在约7900名65岁及以上居民中,3422人(43%)参与了该项目(中位年龄:84岁;范围:70 - 114岁;女性占56.7%)。在超过14559人年的观察期内,295名参与者患上了肺炎。接种疫苗后的发病率为每1000人年20.3例(95%置信区间[CI],18.0 - 22.7)。中断时间序列分析表明,项目实施后世罗町的肺炎死亡率降低了25%,将项目实施前每1000人口每年增加0.23例转变为项目实施后每1000人口每年减少0.04例。

结论

本研究通过基于社区的研究提供了关于23价肺炎球菌多糖疫苗接种与一般老年人之间关联的真实世界证据。这些结果对于23价肺炎球菌多糖疫苗血清型流行的地区可能特别有用,为面临老龄化挑战的地区提供了见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d4/11979344/7c9478d74aa4/je-35-237-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验